Manatuck Hill Partners, LLC Neuronetics, Inc. Transaction History
Manatuck Hill Partners, LLC
- $248 Million
- Q2 2025
A detailed history of Manatuck Hill Partners, LLC transactions in Neuronetics, Inc. stock. As of the latest transaction made, Manatuck Hill Partners, LLC holds 920,000 shares of STIM stock, worth $2.9 Million. This represents 1.29% of its overall portfolio holdings.
Number of Shares
920,000
Previous 920,000
-0.0%
Holding current value
$2.9 Million
Previous $3.39 Million
5.17%
% of portfolio
1.29%
Previous 1.7%
Shares
3 transactions
Others Institutions Holding STIM
# of Institutions
97Shares Held
18.6MCall Options Held
49.6KPut Options Held
78.8K-
Vanguard Group Inc Valley Forge, PA2.74MShares$8.64 Million0.0% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA1.74MShares$5.48 Million1.44% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.51MShares$4.75 Million0.01% of portfolio
-
Ikarian Capital, LLC Dallas, TX1.1MShares$3.46 Million1.17% of portfolio
-
Masters Capital Management LLC Atlanta, GA1MShares$3.15 Million0.14% of portfolio
About Neuronetics, Inc.
- Ticker STIM
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 27,022,800
- Market Cap $85.1M
- Description
- Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...